News and Announcements
OZ Medicann to expand corporate structure enhancing its ability to provide products for the Australian and International markets
- Published February 28, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
OZ Medicann Pty Ltd is enhancing its ability to provide class-leading, patient-centric, development and supply medicinal cannabis products for the Australian and International markets
The restructure which will involve the creation of a new head company, Oz Medicann Group Pty Ltd, under which will reside:
- Oz Medicann P/L focused primarily on the cultivation, research, production and supply of
medicinal cannabis solutions - Educann P/L which will deliver education, certification and accreditation to the medical
practitioners and medicinal cannabis prescribers, and - Hemp OZ P/L commercialise related products and services that are derived from the cannabis
plant.
All entities will generate sustainable revenue that will fund the short and medium and longer terms growth of the Group.
Unlike other medicinal cannabis companies, the OZ Medicann Group will control the entire medicinal cannabis supply chain, from seedling to researcher to patient. The objective of the OZ Medicann Group is to deliver the highest quality medicinal and therapeutic solutions to those who most need them the most – the Patients. With its focus on the sustainable production of high-quality medicinal cannabis solutions, the company will derive revenue from all sources in order to support this outcome.
The OZ Medicann Group is also pleased to announce the appointment of Lucy Haslam to its Board of Directors. Having Lucy on the Board further cements the Group’s commitment to patient-centric research and production and supply of medicinal cannabis solutions. Lucy is the leading advocate and driving force behind the legalisation of medicinal cannabis in Australia and we are thrilled to have Lucy join our team.
The OZ Medicann Group is also pleased to announce, in partnership with United in Compassion, the commencement soon of the largest patient-centric research on medicinal cannabis use in this country. A final announcement will be made shortly on the research partner who will undertake the survey.
The Group’s licence applications are with the Office of Drug Control and are being assessed for production, supply and research. The Group’s growing facility preparations are underway anticipated for quarter 4.
About OZ Medicann
OZ Medicann is a leading Australian Cannabis and Hemp cultivator that produces medicinal solutions, consumer products and education programs for medical practitioners.
Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Australia has not held 90 days of fuel since 2012. The fix may start at a sewage plant.
A decommissioned council treatment site in Bundaberg is being built into a $188.9 million biorefinery. Its managing director is candid that the largest revenue line is not yet contracted. Australia has not met its international 90-day fuel reserve obligation since 2012. Around 90 per cent of the country’s liquid fuel is imported. Andy Whitmore, Managing […]
Backed By Leading Investment Groups and Family Offices
